Condition

Relapse Multiple Myeloma clinical trials and research

• 10Clinical trials
• 4Countries

Newest Relapse Multiple Myeloma clinical trials

All recruiting trials (10)

• Selinexor with Carfilzomib, Isatuximab and Dexamethasone for relapsed or refractory multiple myeloma

  This trial tests whether a four-drug combination can help adults with relapsed or refractory multiple myeloma when they've had at least one prior treatment.

  Recruiting Phase 1/2 Hoosier Cancer Research Network · Madison, Wisconsin · NCT07479979

• DC/MM fusion vaccine plus BCMA CAR-T for relapsed or refractory multiple myeloma

  This trial will test whether adding a personalized DC/MM fusion vaccine (with GM‑CSF) to standard BCMA CAR‑T therapy helps people with relapsed or refractory multiple myeloma.

  Recruiting Phase 1 Beth Israel Deaconess Medical Center · Boston, Massachusetts · NCT07377435

• Dual-target CD19/BCMA CAR-T therapy for relapsed or refractory multiple myeloma

  This study will try a CAR-T treatment that targets both CD19 and BCMA to see if it helps people whose multiple myeloma has returned or not responded to prior therapies.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou · NCT07359014

• FT836 CAR T-cell Therapy with Daratumumab in relapsed/refractory multiple myeloma

  This phase 1 study tests whether FT836 CAR T cells given with daratumumab are safe and show early signs of activity in adults with relapsed or refractory multiple myeloma who have had at least three prior therapies.

  Recruiting Phase 1 Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07221032

• Talquetamab bridging therapy followed by ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

  This trial tests whether giving talquetamab as a temporary bridging treatment before cilta‑cel is safe and feasible for people with relapsed or refractory multiple myeloma who plan to receive CAR‑T therapy.

  Recruiting Phase 1 Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07093554

• Personalized dendritic cell–myeloma fusion vaccine combined with elranatamab for relapsed or refractory multiple myeloma

  This will try a personalized dendritic cell–myeloma fusion vaccine given with elranatamab in people with relapsed or refractory multiple myeloma.

  Recruiting at 2 sites Phase 1 Beth Israel Deaconess Medical Center · Boston, Massachusetts and 1 other locations · NCT06799026

• Comparing treatments for advanced multiple myeloma with and without dexamethasone

  This study is testing whether stopping dexamethasone after the first cycle of chemotherapy helps people with advanced multiple myeloma feel better compared to continuing it until their disease gets worse.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT06561854

• Using elranatamab to treat relapsed/refractory multiple myeloma

  This study is testing if a new drug called elranatamab can help people with tough-to-treat multiple myeloma feel better and keep their disease from getting worse.

  Recruiting at 3 sites Phase 2 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT06138275

• Combination treatment for relapsed multiple myeloma

  This study is testing a new combination treatment for people with relapsed multiple myeloma who haven't had success with standard therapies to see if it helps them feel better.

  Recruiting at 2 sites Phase 2 University of Chicago · Chicago, Illinois and 1 other locations · NCT05789303

• CAR-T therapy targeting BCMA for multiple myeloma patients

  This study is testing a new CAR-T therapy for people with tough-to-treat multiple myeloma to see if it is safe and effective.

  Recruiting Phase 1/2 Sheba Medical Center · Ramat Gan · NCT05243212

Related topics

Quick answers

How many Relapse Multiple Myeloma clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (7 trials), Israel (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Phase 1/2: 2, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →